Clinically, the spectrum of changes referred to as Stroke–Heart Syndrome encompasses electrocardiographic alterations and arrhythmias, acute myocardial damage indicated by elevated cTnI, left ventricular dysfunction, heart failure, TTS, acute myocardial infarction, or sudden cardiac death [49,50]. Here, TNNI3 is linked to myocardial infarction.